One health concept: the link between humans, animals and environment
With over a decade of dedicated expertise, Vibiosphen stands as a leading authority in the field of infectious diseases, championing an integrated One Health strategy that bridges the gap between human and animal health. Our comprehensive approach reflects a deep understanding of the interconnected nature of ecosystems, emphasizing the critical importance of holistic health management to tackle infectious diseases effectively.
Explore our innovative models through microbiology expertise
At Vibiosphen, we are specialized in creating and applying sophisticated preclinical models meticulously designed to mimic real-life clinical scenarios. Our extensive portfolio includes detailed animal models, state-of-the-art in vitro systems, advanced microbiota analysis, and innovative organoid technologies. This suite of multidisciplinary models allows us to comprehensively study and respond to the complex dynamics of infectious pathogens, including bacteria, viruses, fungi, and particularly those related to antimicrobial resistance.
In vitro/ex vivo testing
Antiviral and antibody evaluation
Antibacterial and antifungal
In vitro/ex vivo cytotoxicity
In vivo safety
In vivo
By fighting antimicrobial resistance, we act for tomorrow’s global health
As antimicrobial resistance continues to bring significant global threats and viral infections emerge as increasingly serious challenges to society, Vibiosphen remains steadfastly committed to innovation and scientific excellence. Our robust research frameworks and rigorous testing protocols drive meaningful contributions to global health advancements, fostering sustainable solutions in disease management through translational preclinical tools.
Redefining our understanding of resistance and infections through innovation
Bacteria
Gram negative and Gram positive, aerobic/anaerobic, pathogenic/commensal resistant bacterial strains, ESKAPE.
Viruses/Phages
DNA and RNA virus, Sars-CoV-2, influenza H1N1, RSV A2, MS2 phage, dengue, west nile virus.
Fungi
Candida, Aspergillus, Trichophyton, Malassezia.
Human and animal health expertise
We collaborate closely with pharmaceutical companies, biotech firms, research institutions, and public health organizations worldwide, assisting in accelerating the development and validation of novel therapeutics, and preventive strategies.
Relevant expertise and services
Safety
Standardized safety assays provide access to insightful data on your compound
In vitro efficacy
Actionable in vitro testing tools to access to the first row of sharp data
In vivo efficacy
Actionable in vivo testing tools to access high-level, robust data
PK / PD
Pharmacokinetic / Pharmacodynamic
Lung Organoids
An innovative preclinical model of pulmonary infections
Microbiota
The functional preclinical model opens new kinds of data to be analyzed
Host response
Immunity and inflammation & Vaccine development support
Environment
Material and environment testing